相关实验视频
Updated: Jun 6, 2025

12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.4K
信号通路和针对性疗法在尤宁肉瘤
1Department of Orthopaedics, Union hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Pharmacology & therapeutics
|December 2, 2024
概括
尤文瘤是一种罕见的儿童骨癌,由融合蛋白驱动. 尽管取得了进展,转移病例仍需要新的治疗方法,这凸显了对向治疗和免疫疗法的研究的必要性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 尤文肉瘤是第二个最常见的恶性骨瘤,主要影响儿童和青少年.
- 它的特点是具有攻击性行为,并且与由染色体转位引起的特定融合蛋白有关.
- 目前的多式疗法可以改善局部疾病的存活率,但转移性尤文肉瘤的预后不好.
研究的目的:
- 提供一个全面的Ewing瘤病变的综述,专注于融合蛋白和信号通路.
- 讨论目前和新兴的针对性疗法和免疫疗法来治疗尤宁肉瘤.
- 确定当前理解的局限性,并建议未来的研究方向.
主要方法:
- 关于尤文肉瘤病原,分子机制和治疗策略的文献评论.
- 对信号通路和分子的分析对尤文肉瘤发育至关重要.
- 综合针对性疗法和免疫疗法的信息.
主要成果:
- 融合蛋白是通过改变信号通路,在尤文肉瘤中致癌转化的关键驱动因素.
- 诊断和多模式治疗的进步改善了局部瘤的治疗结果.
- 转移性尤文肉瘤仍然是一个重大的临床挑战,有效治疗方法有限.
结论:
- 更深入地了解尤文肉瘤的发病因子对于开发有效的治疗方法至关重要.
- 向疗法和免疫疗法有希望,但需要进一步研究.
- 未来的研究应该专注于将分子洞察力转化为改善所有尤宁肉瘤患者的临床结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K

